JB Chemicals & Pharmaceuticals Limited - Asset Resilience Ratio

Latest as of March 2026: 14.87%

JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) has an Asset Resilience Ratio of 14.87% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Rs7.39 Billion

≈ $79.91 Million USD Cash + Short-term Investments

Total Assets

Rs49.69 Billion

≈ $537.34 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2006–2026)

This chart shows how JB Chemicals & Pharmaceuticals Limited's Asset Resilience Ratio has changed over time. Check JBCHEPHARM strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down JB Chemicals & Pharmaceuticals Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see JBCHEPHARM market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs7.39 Billion	14.87%
Total Liquid Assets	Rs7.39 Billion	14.87%

Asset Resilience Insights

Moderate Liquidity: JB Chemicals & Pharmaceuticals Limited has 14.87% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

JB Chemicals & Pharmaceuticals Limited Industry Peers by Asset Resilience Ratio

Compare JB Chemicals & Pharmaceuticals Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Shan Dong Dong-E E-Jiao Co Ltd SHE:000423	Drug Manufacturers - Specialty & Generic	20.44%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	48.48%
Tasly Pharmaceutical Group Co Ltd SHG:600535	Drug Manufacturers - Specialty & Generic	11.69%
Chengdu Kanghong Pharmaceuticals Group Co Ltd SHE:002773	Drug Manufacturers - Specialty & Generic	4.31%
Tibet Rhodiola Pharmaceutical Holding Co SHG:600211	Drug Manufacturers - Specialty & Generic	15.57%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Changzhou Qianhong Biopharma Co Ltd SHE:002550	Drug Manufacturers - Specialty & Generic	18.70%

Annual Asset Resilience Ratio for JB Chemicals & Pharmaceuticals Limited (2006–2026)

The table below shows the annual Asset Resilience Ratio data for JB Chemicals & Pharmaceuticals Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2026-03-31	14.87%	Rs7.39 Billion ≈ $79.91 Million	Rs49.69 Billion ≈ $537.34 Million	+6.19pp
2025-03-31	8.68%	Rs3.71 Billion ≈ $40.12 Million	Rs42.74 Billion ≈ $462.19 Million	-1.21pp
2024-03-31	9.89%	Rs3.95 Billion ≈ $42.71 Million	Rs39.94 Billion ≈ $431.95 Million	+3.05pp
2023-03-31	6.83%	Rs2.43 Billion ≈ $26.26 Million	Rs35.54 Billion ≈ $384.34 Million	+6.76pp
2022-03-31	0.07%	Rs19.26 Million ≈ $208.31K	Rs26.07 Billion ≈ $281.98 Million	-29.79pp
2021-03-31	29.86%	Rs6.68 Billion ≈ $72.28 Million	Rs22.38 Billion ≈ $242.04 Million	+9.86pp
2020-03-31	20.01%	Rs3.63 Billion ≈ $39.24 Million	Rs18.14 Billion ≈ $196.13 Million	-0.98pp
2019-03-31	20.99%	Rs3.76 Billion ≈ $40.65 Million	Rs17.91 Billion ≈ $193.69 Million	-1.10pp
2018-03-31	22.09%	Rs3.90 Billion ≈ $42.16 Million	Rs17.65 Billion ≈ $190.87 Million	+8.65pp
2017-03-31	13.44%	Rs2.25 Billion ≈ $24.33 Million	Rs16.74 Billion ≈ $181.04 Million	+0.90pp
2016-03-31	12.54%	Rs1.95 Billion ≈ $21.12 Million	Rs15.57 Billion ≈ $168.43 Million	-24.84pp
2015-03-31	37.38%	Rs5.56 Billion ≈ $60.12 Million	Rs14.87 Billion ≈ $160.84 Million	+0.58pp
2014-03-31	36.81%	Rs4.97 Billion ≈ $53.78 Million	Rs13.51 Billion ≈ $146.11 Million	+6.20pp
2013-03-31	30.61%	Rs3.98 Billion ≈ $43.04 Million	Rs13.00 Billion ≈ $140.61 Million	+5.65pp
2012-03-31	24.96%	Rs2.99 Billion ≈ $32.33 Million	Rs11.98 Billion ≈ $129.54 Million	+18.14pp
2011-03-31	6.82%	Rs681.15 Million ≈ $7.37 Million	Rs9.99 Billion ≈ $108.08 Million	-0.32pp
2010-03-31	7.13%	Rs596.82 Million ≈ $6.45 Million	Rs8.37 Billion ≈ $90.51 Million	-0.64pp
2009-03-31	7.77%	Rs579.99 Million ≈ $6.27 Million	Rs7.46 Billion ≈ $80.71 Million	-0.34pp
2008-03-31	8.11%	Rs601.32 Million ≈ $6.50 Million	Rs7.41 Billion ≈ $80.17 Million	+2.87pp
2007-03-31	5.24%	Rs373.14 Million ≈ $4.04 Million	Rs7.12 Billion ≈ $77.03 Million	-0.01pp
2006-03-31	5.25%	Rs265.04 Million ≈ $2.87 Million	Rs5.05 Billion ≈ $54.64 Million	--

pp = percentage points

About JB Chemicals & Pharmaceuticals Limited

NSE:JBCHEPHARM India Drug Manufacturers - Specialty & Generic

Market Cap

$4.18 Billion

Rs386.77 Billion INR

Market Cap Rank

#3956 Global

#179 in India

Share Price

Rs2408.90

Change (1 day)

-3.87%

52-Week Range

Rs1656.70 - Rs2506.00

All Time High

Rs2506.00